Professor Abhilasha Karkey
Contact information
Podcast interview
Infectious diseases in Nepal

The primary goal of OUCRU-Nepal is improving public health in Nepal and South Asia, focusing on typhoid, antimicrobial resistance, and dengue increase linked with climate change. Over the recent years, the TCV typhoid vaccine trial emphasized the importance of regional collaboration and working with policymakers. OUCRU-Nepal has built strong hospital and community relationships, boosting global visibility and collaborations.
Abhilasha Karkey
Associate Professor
- Medical Microbiologist
- Director of OUCRU Nepal
OUCRU Nepal
Abhilasha Karkey is a medical microbiologist at the Oxford University Clinical Research Unit in Kathmandu, Nepal.
Her current research focus is on antimicrobial resistance in Gram-negative pathogens (Klebsiella pneumonia and Enterobacter spp) with a specific focus on the enteric pathogens Salmonella Typhi and Paratyphi A. She leads research studies focusing on the surveillance of resistant pathogens and works in close collaboration with hospitals to devise appropriate antimicrobial stewardship and infection prevention-control programmes.
Of specific interest for her are the enteric fever pathogens, Salmonella Typhi and Paratyphi. In addition to monitoring the resistance in these pathogens, she is working towards the elimination of enteric fever in Nepal: could this be a case study for the elimination of other similar infectious diseases?
Recent publications
-
Research Electronic Data Capture (REDCap) for Population-Based Data Collection in Low- and Middle-Income Countries: Opportunities, Challenges, and Solutions.
Le HT. et al, (2025), J Med Internet Res, 27
-
Life from death: ethical implications of uterus transplantation from deceased donors in global health
Suwalowska H. et al, (2025), BMJ Global Health, 10, e018216 - e018216
-
Identifying context-specific determinants to inform improvement of antimicrobial stewardship implementation in healthcare facilities in Asia: results from a scoping review and web-based survey among local experts.
Limato R. et al, (2025), BMJ open quality, 14
-
The <i>Salmonella</i> Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates.
Pinto M. et al, (2025), Vaccines, 13
-
Modelling Salmonella Typhi in high-density urban Blantyre neighbourhood, Malawi, using point pattern methods
Khaki JJ. et al, (2024), Scientific Reports, 14